It was even proposed that the anti-tumor immunity resulting from chemotherapy may be mediated by ATP release from tumor cells and the activation of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome [15], thus suggesting the participation of the purinergic receptor P2X7 [16,17]. Here, P2RY1 is linked to neoplasm.